{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:28:19Z","timestamp":1794947299881,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Seminar on Studies on Globality of the National Autonomous University of Mexico"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perception of drug adulteration has increased in Mexico, but there is little research on adulterants and toxicity. The aim of this study was to identify drug composition in an electronic music outdoor festival nearby Mexico City.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The participants completed a questionnaire with demographic data, harm reduction strategies, drug-use patterns, history, and the drug they expected to find. We took a small sample of each substance and prepared it for drug checking. A two-section drug testing station was placed within the grounds of the festival. Interaction with participants occurred at the front part. Drug checking was conducted at the rear part. The service was free of charge, voluntary and confidential. Forty persons aged 22 to 48\u00a0years participated (mode\u2009=\u200928), of which 92.5% were male, most (82.5%) were single. Through the Substance Analysis Program of \u201cReverdeSer Collective,\u201d we conducted the testing with the attendants that provided 51 drug samples, following ethical and biosafety protocols. We used colorimetry, Fourier Transform Infrared Spectroscopy, and fentanyl immunoassay strips for sample analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Substances of choice among attendants were psychostimulants (MDMA and other amphetamine-like drugs) and hallucinogens. Most samples contained what the users expected plus adulterants. Main adulterants were methylene-dioxy-ethyl-amphetamine, methylene-dioxy-propyl-amphetamine, hydroxyamphetamine, and the selective serotonin reuptake inhibitor venlafaxine. Fentanyl was present in 2 out of 4 cocaine samples and in 14 of the 22 confirmed MDMA samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Some of the adulterants found pose serious health risks, especially fentanyl, amphetamine-like substances, and venlafaxine. Therefore, it is urgent to monitor these adulterants at electronic music festivals and to implement prevention, treatment, and harm reduction public policies. Naloxone distribution and drug-assisted therapies should be part of government programs in Mexico.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-023-00905-8","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T22:01:56Z","timestamp":1701813716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["First drug-checking study at an electronic festival and fentanyl detection in the central region of Mexico"],"prefix":"10.1186","volume":"20","author":[{"given":"Silvia L.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bencomo-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E.","family":"Medina-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"V\u00e1zquez-Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Fleiz-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"905_CR1","unstructured":"Global Commission on Drug Policy. TIME TO END PROHIBITION. Youtube; [cited 2022 Sep 3]. Available from: https:\/\/www.youtube.com\/c\/GlobalCommissiononDrugPolicy."},{"issue":"2","key":"905_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/dta.220","volume":"3","author":"C Cole","year":"2011","unstructured":"Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3(2):89\u201396. https:\/\/doi.org\/10.1002\/dta.220.","journal-title":"Drug Test Anal"},{"key":"905_CR3","unstructured":"Pascale A. Drug adulterants and their effects on the health of users: a critical review. 2019. Available from: http:\/\/www.cicad.oas.org\/oid\/pubs\/Final ENG Drug adulterants and their effects on the health of users\u2014a pdf."},{"key":"905_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.00078","volume":"14","author":"JB Zawilska","year":"2020","unstructured":"Zawilska JB, Kacela M, Adamowicz P. NBOMes\u2013highly potent and toxic alternatives of LSD. Front Neurosci. 2020;14:1\u201315. https:\/\/doi.org\/10.3389\/fnins.2020.00078.","journal-title":"Front Neurosci"},{"issue":"107589","key":"905_CR5","doi-asserted-by":"publisher","first-page":"107589","DOI":"10.1016\/j.drugalcdep.2019.107589","volume":"205","author":"K McCrae","year":"2019","unstructured":"McCrae K, Tobias S, Tupper K, Arredondo J, Henry B, Mema S, et al. Drug checking services at music festivals and events in a Canadian setting. Drug Alcohol Depend. 2019;205(107589):107589. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107589.","journal-title":"Drug Alcohol Depend"},{"key":"905_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.forsciint.2016.04.016","volume":"263","author":"C Vidal Gin\u00e9","year":"2016","unstructured":"Vidal Gin\u00e9 C, Ventura Vilamala M, Forn\u00eds Espinosa I, Gil Lladanosa C, Calzada \u00c1lvarez N, Fit\u00f3 Fruit\u00f3s A, et al. Crystals and tablets in the Spanish ecstasy market 2000\u20132014: are they the same or different in terms of purity and adulteration? Forensic Sci Int. 2016;263:164\u20138. https:\/\/doi.org\/10.1016\/j.forsciint.2016.04.016.","journal-title":"Forensic Sci Int"},{"issue":"4","key":"905_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/add.14868","volume":"115","author":"L Hondebrink","year":"2020","unstructured":"Hondebrink L, Nugteren-van Lonkhuyzen JJ, Hunault CC, van den Berg J, van der Gouwe D, van Riel AJHP. New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017. Addiction. 2020;115(4):716\u201325. https:\/\/doi.org\/10.1111\/add.14868.","journal-title":"Addiction"},{"issue":"2","key":"905_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1590\/s0104-12902015000200020","volume":"24","author":"D Martins","year":"2015","unstructured":"Martins D, Valente H, Pires C. Check!ng: the last frontier for Harm Reduction in party settings. Saude e Soc. 2015;24(2):646\u201360. https:\/\/doi.org\/10.1590\/s0104-12902015000200020.","journal-title":"Saude e Soc."},{"key":"905_CR9","doi-asserted-by":"crossref","unstructured":"Grabenhofer S, Kociper K, Nagy C, Luf A, Schmid R. Drug checking und aufkl\u00e4rung vor ort in der niedrigschwelligen pr\u00e4ventionsarbeit [Drug checking and on-site reconnaissance in low-threshold prevention work]. In: von Heyden M, Jungaberle H, Majic T, editors. Handbuch Psychoaktive Substanzen. Berlin; 2016. 16.","DOI":"10.1007\/978-3-642-55214-4_7-1"},{"key":"905_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-8-16","author":"I Hungerbuehler","year":"2011","unstructured":"Hungerbuehler I, Buecheli A, Schaub M. Drug checking: a prevention measure for a heterogeneous group with high consumption frequency and polydrug use - evaluation of zurich\u2019s drug checking services. Harm Reduct J. 2011. https:\/\/doi.org\/10.1186\/1477-7517-8-16.","journal-title":"Harm Reduct J."},{"issue":"10","key":"905_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2174\/1570159x18666200413142632","volume":"18","author":"A Guirguis","year":"2020","unstructured":"Guirguis A, Moosa I, Gittins R, Schifano F. What about drug checking? systematic review and netnographic analysis of social media. Curr Neuropharmacol. 2020;18(10):906\u201317. https:\/\/doi.org\/10.2174\/1570159x18666200413142632.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"905_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/dar.12576","volume":"37","author":"MJ Barratt","year":"2018","unstructured":"Barratt MJ, Bruno R, Ezard N, Ritter A. Pill testing or drug checking in Australia: acceptability of service design features. Drug Alcohol Rev. 2018;37(2):226\u201336. https:\/\/doi.org\/10.1111\/dar.12576.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"905_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u201344. https:\/\/doi.org\/10.1111\/add.15734.","journal-title":"Addiction"},{"key":"905_CR14","unstructured":"Brunt T. Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges Background paper commissioned by the EMCDDA for Health and social responses to drug problems: a European guide Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges Dr Tibor Brunt Drug Information and Monitoring System, the Netherlands. 2017."},{"issue":"3","key":"905_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2116\/analsci.15.289","volume":"15","author":"M Hida","year":"1999","unstructured":"Hida M, Mitsui T. Rapid identification of lysergic acid diethylamide in blotter paper by microscope FT-IR. Anal Sci. 1999;15(3):289\u201391. https:\/\/doi.org\/10.2116\/analsci.15.289.","journal-title":"Anal Sci"},{"key":"905_CR16","unstructured":"Bencomo-Cruz M, Pineda-Miranda F. Programa de An\u00e1lisis de Sustancias (PAS). Cinco a\u00f1os de una iniciativa para la reducci\u00f3n de da\u00f1os asociados al uso de sustancias psicoactivas en M\u00e9xico. Mexico; 2021."},{"issue":"4","key":"905_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/add.14934","volume":"115","author":"C Fleiz","year":"2020","unstructured":"Fleiz C, Arredondo J, Chavez A, Pacheco L, Segovia LA, Villatoro JA, et al. Fentanyl is used in Mexico\u2019s northern border: current challenges for drug health policies. Addiction. 2020;115(4):778\u201381. https:\/\/doi.org\/10.1111\/add.14934.","journal-title":"Addiction"},{"issue":"103678","key":"905_CR18","doi-asserted-by":"publisher","first-page":"103678","DOI":"10.1016\/j.drugpo.2022.103678","volume":"104","author":"J Friedman","year":"2022","unstructured":"Friedman J, Bourgois P, Godvin M, Chavez A, Pacheco L, Segovia LA, et al. The introduction of fentanyl on the US\u2013Mexico border: An ethnographic account triangulated with drug checking data from Tijuana. Int J Drug Policy. 2022;104(103678):103678. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103678.","journal-title":"Int J Drug Policy."},{"issue":"12","key":"905_CR19","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/j.1360-0443.2009.02707.x","volume":"104","author":"N Vogels","year":"2009","unstructured":"Vogels N, Brunt TM, Rigter S, Van Dijk P, Vervaeke H, Niesink RJM. Content of ecstasy in the Netherlands: 1993\u20132008. Addiction. 2009;104(12):2057\u201366. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02707.x.","journal-title":"Addiction"},{"issue":"8","key":"905_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1177\/0269881117715596","volume":"31","author":"S Saleemi","year":"2017","unstructured":"Saleemi S, Pennybaker SJ, Wooldridge M, Johnson MW. Who is \u201cMolly\u201d? MDMA adulterants by product name and the impact of harm-reduction services at raves. J Psychopharmacol. 2017;31(8):1056\u201360. https:\/\/doi.org\/10.1177\/0269881117715596.","journal-title":"J Psychopharmacol"},{"issue":"108006","key":"905_CR21","doi-asserted-by":"publisher","first-page":"108006","DOI":"10.1016\/j.drugalcdep.2020.108006","volume":"212","author":"L Ti","year":"2020","unstructured":"Ti L, Tobias S, Lysyshyn M, Laing R, Nosova E, Choi JC, et al. Detecting fentanyl using point-of-care drug checking technologies: a validation study. Drug Alcohol Depend. 2020;212(108006):108006. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108006.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"905_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12954-018-0208-z","volume":"15","author":"M Sande","year":"2018","unstructured":"Sande M, \u0160abi\u0107 S. The importance of drug checking outside the context of nightlife in Slovenia. Harm Reduct J. 2018;15(1):2. https:\/\/doi.org\/10.1186\/s12954-018-0208-z.","journal-title":"Harm Reduct J"},{"issue":"4","key":"905_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/dar.12263","volume":"34","author":"KI Morley","year":"2015","unstructured":"Morley KI, Lynskey MT, Moran P, Borschmann R, Winstock AR. Polysubstance use, mental health and high-risk behaviours: results from the 2012 global drug survey. Drug Alcohol Rev. 2015;34(4):427\u201337. https:\/\/doi.org\/10.1111\/dar.12263.","journal-title":"Drug Alcohol Rev"},{"issue":"2\u20133","key":"905_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2010.08.010","volume":"113","author":"GW Smith","year":"2011","unstructured":"Smith GW, Farrell M, Bunting BP, Houston JE, Shevlin M. Patterns of polydrug use in Great Britain: Findings from a national household population survey. Drug Alcohol Depend. 2011;113(2\u20133):222\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.08.010.","journal-title":"Drug Alcohol Depend"},{"key":"905_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addbeh.2017.11.004","volume":"78","author":"F Fern\u00e1ndez-Calder\u00f3n","year":"2018","unstructured":"Fern\u00e1ndez-Calder\u00f3n F, Cleland CM, Palamar JJ. Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances. Addict Behav. 2018;78:85\u201393. https:\/\/doi.org\/10.1016\/j.addbeh.2017.11.004.","journal-title":"Addict Behav"},{"issue":"3","key":"905_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1037\/pha0000452","volume":"29","author":"JJ Palamar","year":"2021","unstructured":"Palamar JJ, Fitzgerald ND, Keyes KM, Cottler LB. Drug checking at dance festivals: a review with recommendations to increase generalizability of findings. Exp Clin Psychopharmacol. 2021;29(3):229\u201335. https:\/\/doi.org\/10.1037\/pha0000452.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"905_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0205-7","volume":"15","author":"N Day","year":"2018","unstructured":"Day N, Criss J, Griffiths B, Gujral SK, John-Leader F, Johnston J, et al. Music festival attendees\u2019 illicit drug use, knowledge and practices regarding drug content and purity: a cross-sectional survey. Harm Reduct J. 2018;15(1):1. https:\/\/doi.org\/10.1186\/s12954-017-0205-7.","journal-title":"Harm Reduct J"},{"issue":"8","key":"905_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/bs10080121","volume":"10","author":"A Guirguis","year":"2020","unstructured":"Guirguis A, Gittins R, Schifano F. Piloting the UK\u2019s first home-office-licensed pharmacist-led drug checking service at a community substance misuse service. Behav Sci. 2020;10(8):121. https:\/\/doi.org\/10.3390\/bs10080121.","journal-title":"Behav Sci"},{"issue":"1","key":"905_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","volume":"15","author":"M Karamouzian","year":"2018","unstructured":"Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15(1):46. https:\/\/doi.org\/10.1186\/s12954-018-0252-8.","journal-title":"Harm Reduct J"},{"issue":"1","key":"905_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","volume":"18","author":"TLE Lockwood","year":"2021","unstructured":"Lockwood TLE, Vervoordt A, Lieberman M. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduct J. 2021;18(1):30. https:\/\/doi.org\/10.1186\/s12954-021-00478-4.","journal-title":"Harm Reduct J"},{"key":"905_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102661","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102661.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"905_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/dta.1954","volume":"9","author":"TM Brunt","year":"2017","unstructured":"Brunt TM, Nagy C, B\u00fccheli A, Martins D, Ugarte M, Beduwe C, et al. Drug testing in Europe: monitoring results of the trans european drug information (TEDI) project. Drug Test Anal. 2017;9(2):188\u201398. https:\/\/doi.org\/10.1002\/dta.1954.","journal-title":"Drug Test Anal"},{"issue":"8","key":"905_CR33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/jat\/bky051","volume":"42","author":"AJ Krotulski","year":"2018","unstructured":"Krotulski AJ, Mohr ALA, Fogarty MF, Logan BK. The detection of novel stimulants in oral fluid from users reporting ecstasy, molly and MDMA ingestion. J Anal Toxicol. 2018;42(8):544\u201353. https:\/\/doi.org\/10.1093\/jat\/bky051.","journal-title":"J Anal Toxicol"},{"issue":"6","key":"905_CR34","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00213-021-05876-x","volume":"239","author":"B Malcolm","year":"2022","unstructured":"Malcolm B, Thomas K. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology. 2022;239(6):1881\u201391. https:\/\/doi.org\/10.1007\/s00213-021-05876-x.","journal-title":"Psychopharmacology"},{"issue":"1","key":"905_CR35","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/s41598-021-85389-x","volume":"11","author":"IV Cohen","year":"2021","unstructured":"Cohen IV, Makunts T, Abagyan R, Thomas K. Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database. Sci Rep. 2021;11(1):5997. https:\/\/doi.org\/10.1038\/s41598-021-85389-x.","journal-title":"Sci Rep"},{"issue":"3","key":"905_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/ijamh-2013-0052","volume":"25","author":"Y Dobry","year":"2013","unstructured":"Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013;25(3):193\u20139. https:\/\/doi.org\/10.1515\/ijamh-2013-0052.","journal-title":"Int J Adolesc Med Health"},{"issue":"5\u20136","key":"905_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.17269\/s41997-018-0126-6","volume":"109","author":"SC Mema","year":"2018","unstructured":"Mema SC, Sage C, Xu Y, Tupper KW, Ziemianowicz D, McCrae K, et al. Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia. Can J Public Heal. 2018;109(5\u20136):740\u20134. https:\/\/doi.org\/10.17269\/s41997-018-0126-6.","journal-title":"Can J Public Heal"},{"issue":"1","key":"905_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","volume":"98","author":"F Leri","year":"2003","unstructured":"Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98(1):7\u201322.","journal-title":"Addiction"},{"issue":"1","key":"905_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12954-018-0240-z","volume":"15","author":"JN Park","year":"2018","unstructured":"Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J. 2018;15(1):34. https:\/\/doi.org\/10.1186\/s12954-018-0240-z.","journal-title":"Harm Reduct J"},{"issue":"2","key":"905_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ajad.13115","volume":"30","author":"SN Glick","year":"2021","unstructured":"Glick SN, Klein KS, Tinsley J, Golden MR. Increasing heroin-methamphetamine (Goofball) use and related morbidity among seattle area people who inject drugs. Am J Addict. 2021;30(2):183\u201391. https:\/\/doi.org\/10.1111\/ajad.13115.","journal-title":"Am J Addict"},{"key":"905_CR41","doi-asserted-by":"crossref","unstructured":"Carranza-Aguilar C, Espinosa-Riquer ZP, Martinez-Cuevas FL, Cruz SL. Opioid receptors and neuronal signal transduction. In: Cruz SL, editor. Opioids. Pharmacology, Abuse, and Addiction. Switzerland: Springer, 2022; 175\u2013196.","DOI":"10.1007\/978-3-031-09936-6_9"},{"issue":"4","key":"905_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/yco.0000000000000875","volume":"36","author":"J van Amsterdam","year":"2023","unstructured":"van Amsterdam J, Pierce M, van den Brink W. Predictors and motives of polydrug use in opioid users. A narrative review. Curr Opin Psychiatry. 2023;36(4):301\u20137. https:\/\/doi.org\/10.1097\/yco.0000000000000875.","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"905_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/phn.13193","volume":"40","author":"JJ Palamar","year":"2023","unstructured":"Palamar JJ. Awareness that cocaine can contain fentanyl among nightclub and festival attendees in New York City, 2018\u20132022. Public Health Nurs. 2023;40(4):566\u201371. https:\/\/doi.org\/10.1111\/phn.13193.","journal-title":"Public Health Nurs"},{"key":"905_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugpo.2018.10.001","volume":"62","author":"MK Laing","year":"2018","unstructured":"Laing MK, Tupper KW, Fairbairn N. Drug checking as a potential strategic overdose response in the fentanyl era. Int J Drug Policy. 2018;62:59\u201366.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00905-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00905-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00905-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T22:07:14Z","timestamp":1701814034000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00905-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00905-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2782832\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research procedures reported in this article were approved by the Ramon de la Fuente Mu\u00f1iz National Institute of Psychiatry (Protocol Number CEI C\/057\/2021). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u201cNot applicable\u201d in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}